低级别胶质瘤来源的诱导多能干细胞特征揭示胶质瘤发生中的早期区域染色体扩增
研究从新鲜手术切除的IDH1突变低级别胶质瘤中,通过强制表达山中因子制备iPSC克隆,并测序IDH位点、用微阵列比较基因组杂交分析遗传组成。因含IDH1突变的细胞难以重编程,iPSC克隆均不含IDH1突变,但含原发肿瘤中也存在的区域染色体扩增。TCGA数据库分析显示这些区域染色体扩增也见于部分低级别胶质瘤病例,提示至少部分低级别胶质瘤在获得IDH突变前可能存在区域染色体改变。
要点
- 从IDH1突变低级别胶质瘤制备的iPSC克隆均不含IDH1突变。
- iPSC克隆含有的区域染色体扩增也存在于原发低级别胶质瘤细胞中。
- TCGA低级别胶质瘤数据库分析显示这些区域染色体扩增也见于部分病例。
核心结论
- 低级别胶质瘤原发细胞池中存在一类携带基因扩增但无IDH1突变的细胞亚群。
- 这些区域染色体扩增也见于部分低级别胶质瘤病例,是低频率复发性病变。
- 数据提示至少部分低级别胶质瘤在获得IDH突变前可能存在区域染色体改变。
研究设计与样本
- 从新鲜手术切除的IDH1突变低级别胶质瘤中,通过强制表达山中转录因子制备iPSC克隆。
- 对IDH位点进行测序,并用微阵列比较基因组杂交分析多个iPSC克隆的遗传组成。
- 进一步分析TCGA低级别胶质瘤数据库。
主要发现
- 所有iPSC克隆均不含IDH1突变。
- 微阵列比较基因组杂交分析显示iPSC克隆含有区域染色体扩增,这些扩增也存在于原发低级别胶质瘤细胞中。
- TCGA低级别胶质瘤数据库分析显示这些区域染色体扩增也见于部分低级别胶质瘤病例,频率低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: IDH1 mutation has been identified as an early genetic event driving low grade gliomas (LGGs) and it has been proven to exerts a powerful epigenetic effect. Cells containing IDH1 mutation are refractory to epigenetical reprogramming to iPSC induced by expression of Yamanaka transcription factors, a feature that we employed to study early genetic amplifications or deletions in gliomagenesis. METHODS: We made iPSC clones from freshly surgically resected IDH1 mutant LGGs by forced expression of Yamanaka transcription factors. We sequenced the IDH locus and analyzed the genetic composition of multiple iPSC clones by array-based comparative genomic hybridization (aCGH). RESULTS: We hypothesize that the primary cell pool isolated from LGG tumor contains a heterogeneous population consisting tumor cells at various stages of tumor progression including cells with early genetic lesions if any prior to acquisition of IDH1 mutation. Because cells containing IDH1 mutation are refractory to reprogramming, we predict that iPSC clones should originate only from LGG cells without IDH1 mutation, i.e. cells prior to acquisition of IDH1 mutation. As expected, we found that none of the iPSC clones contains IDH1 mutation. Further analysis by aCGH of the iPSC clones reveals that they contain regional chromosomal amplifications which are also present in the primary LGG cells. CONCLUSIONS: These results indicate that there exists a subpopulation of cells harboring gene amplification but without IDH1 mutation in the LGG primary cell pool. Further analysis of TCGA LGG database demonstrates that these regional chromosomal amplifications are also present in some cases of low grade gliomas indicating they are reoccurring lesions in glioma albeit at a low frequency. Taken together, these data suggest that regional chromosomal alterations may exist prior to the acquisition of IDH mutations in at least some cases of LGGs.
引用
- Liu Z, Che P, Mercado JJ, et al. Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis. J Neurooncol. 2018. PMID: 30460631. doi:10.1007/s11060-018-03047-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。